175 related articles for article (PubMed ID: 6732233)
1. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
Lamothe F; Auger F; Lacroix JM
Antimicrob Agents Chemother; 1984 May; 25(5):662-5. PubMed ID: 6732233
[TBL] [Abstract][Full Text] [Related]
2. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
Lacroix JM; Lamothe F; Malouin F
Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
[TBL] [Abstract][Full Text] [Related]
3. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Maskell JP; Nasu M; Williams JD
J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
5. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
Malouin F; Lamothe F
Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Aldridge KE
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
[TBL] [Abstract][Full Text] [Related]
10. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
[TBL] [Abstract][Full Text] [Related]
14. Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.
Jenkins SG; Birk RJ; Zabransky RJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):628-34. PubMed ID: 7181473
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
17. Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Yotsuji A; Minami S; Kakizawa H; Yasuda T; Takai A; Saikawa I; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Dec; 28(6):773-7. PubMed ID: 3878690
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
Lachance N; Gaudreau C; Lamothe F; Turgeon F
Antimicrob Agents Chemother; 1993 May; 37(5):1174-6. PubMed ID: 8390812
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
20. Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis.
Indiveri MC; Hirsh DC
Am J Vet Res; 1985 Oct; 46(10):2207-9. PubMed ID: 4062030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]